Works matching IS 17597706 AND DT 2020 AND VI 11 AND IP 4

Results: 34

Corrigendum.

Published in:: Thoracic Cancer, 2020, v. 11, n. 4, p. 1114, doi. 10.1111/1759-7714.13402
Publication type:: Article

Osimertinib, a third‐generation EGFR tyrosine kinase inhibitor: A retrospective multicenter study of its real‐world efficacy and safety in advanced/recurrent non‐small cell lung carcinoma.

Published in:

Thoracic Cancer, 2020, v. 11, n. 4, p. 935, doi. 10.1111/1759-7714.13378

By:

Kishikawa, Takayuki;
Kasai, Takashi;
Okada, Masahiko;
Nakachi, Ichiro;
Soda, Sayo;
Arai, Ryo;
Takigami, Ayako;
Sata, Masafumi

Publication type:

Article

A nurse‐driven enhanced recovery after surgery (ERAS) nursing program for geriatric patients following lung surgery.

Published in:

Thoracic Cancer, 2020, v. 11, n. 4, p. 1105, doi. 10.1111/1759-7714.13372

By:

Li, Yan;
Yan, Chuanchuan;
Li, Jing;
Wang, Qiujing;
Zhang, Jing;
Qiang, Wanmin;
Qi, Daliang

Publication type:

Article

Health‐related quality of life in patients with esophageal cancer or precancerous lesions assessed by EQ‐5D: A multicenter cross‐sectional study.

Published in:

Thoracic Cancer, 2020, v. 11, n. 4, p. 1076, doi. 10.1111/1759-7714.13368

By:

Wang, Youqing;
Shi, Jufang;
Du, Lingbin;
Huang, Huiyao;
Wang, Le;
Zhu, Juan;
Li, Huizhang;
Bai, Yana;
Liao, Xianzhen;
Mao, Ayan;
Liu, Guoxiang;
Ren, Jiansong;
Sun, Xiaojie;
Gong, Jiyong;
Zhou, Qi;
Mai, Ling;
Zhu, Lin;
Xing, Xiaojing;
Liu, Yuqin;
Ren, Ying

Publication type:

Article

Patterns of response in metastatic NSCLC during PD‐1 or PD‐L1 inhibitor therapy: Comparison of the RECIST 1.1 and iRECIST criteria.

Published in:

Thoracic Cancer, 2020, v. 11, n. 4, p. 1068, doi. 10.1111/1759-7714.13367

By:

Liang, Hongge;
Xu, Yan;
Chen, Minjiang;
Zhong, Wei;
Wang, Mengzhao;
Zhao, Jing

Publication type:

Article

Salvage surgery for advanced non‐small cell lung cancer after targeted therapy: A case series.

Published in:

Thoracic Cancer, 2020, v. 11, n. 4, p. 1061, doi. 10.1111/1759-7714.13366

By:

Song, Weian;
Di, Shouyin;
Liu, Junqiang;
Fan, Boshi;
Zhao, Jiahua;
Zhou, Shaohua;
Chen, Siyu;
Dong, Hai;
Yue, Caiying;
Gong, Taiqian

Publication type:

Article

Immune checkpoint inhibitor‐associated interstitial lung diseases correlate with better prognosis in patients with advanced non‐small‐cell lung cancer.

Published in:

Thoracic Cancer, 2020, v. 11, n. 4, p. 1052, doi. 10.1111/1759-7714.13364

By:

Sugano, Teppei;
Seike, Masahiro;
Saito, Yoshinobu;
Kashiwada, Takeru;
Terasaki, Yasuhiro;
Takano, Natsuki;
Hisakane, Kakeru;
Takahashi, Satoshi;
Tanaka, Toru;
Takeuchi, Susumu;
Miyanaga, Akihiko;
Minegishi, Yuji;
Noro, Rintaro;
Kubota, Kaoru;
Gemma, Akihiko

Publication type:

Article

Severe hepatotoxicity due to osimertinib after nivolumab therapy in patients with non‐small cell lung cancer harboring EGFR mutation.

Published in:

Thoracic Cancer, 2020, v. 11, n. 4, p. 1045, doi. 10.1111/1759-7714.13363

By:

Yamaguchi, Ou;
Kaira, Kyoichi;
Kawasaki, Tomonori;
Mouri, Atsuto;
Hashimoto, Kosuke;
Shiono, Ayako;
Shinomiya, Shun;
Miura, Yu;
Nishihara, Fuyumi;
Murayama, Yoshitake;
Kobayashi, Kunihiko;
Mochida, Satoshi;
Kagamu, Hiroshi

Publication type:

Article

Pathologic complete response to preoperative immunotherapy in a lung adenocarcinoma patient with bone metastasis: A case report.

Published in:

Thoracic Cancer, 2020, v. 11, n. 4, p. 1094, doi. 10.1111/1759-7714.13361

By:

Tang, Yong;
Li, Yadan;
Zhang, Lei;
Tong, Guihui;
Ou, Zhu'an;
Wang, Zhuocai;
Zhang, Henghui;
Qiao, Guibin

Publication type:

Article

Number of metastatic organs negatively affects the treatment sequence in patients with EGFR‐TKI failure.

Published in:

Thoracic Cancer, 2020, v. 11, n. 4, p. 1038, doi. 10.1111/1759-7714.13360

By:

Mizuno, Takaaki;
Horinouchi, Hidehito;
Watanabe, Sho;
Sato, Jun;
Morita, Ryo;
Murakami, Shuji;
Goto, Yasushi;
Kanda, Shintaro;
Fujiwara, Yutaka;
Yamamoto, Noboru;
Ohe, Yuichiro

Publication type:

Article

Response rate of patients with baseline brain metastases from recently diagnosed non‐small cell lung cancer receiving radiotherapy according to EGFR, ALK and KRAS mutation status.

Published in:

Thoracic Cancer, 2020, v. 11, n. 4, p. 1026, doi. 10.1111/1759-7714.13359

By:

Arrieta, Oscar;
Ramírez‐Tirado, Laura‐Alejandra;
Caballé‐Perez, Enrique;
Mejia‐Perez, Alberto;
Zatarain‐Barrón, Zyanya Lucia;
Cardona, Andrés F.;
Lozano‐Ruíz, Francisco;
Segura‐González, Manuel;
Cruz‐Rico, Graciela;
Maldonado, Federico;
Rosell, Rafael

Publication type:

Article

TRIAP1 knockdown sensitizes non‐small cell lung cancer to ionizing radiation by disrupting redox homeostasis.

Published in:

Thoracic Cancer, 2020, v. 11, n. 4, p. 1015, doi. 10.1111/1759-7714.13358

By:

Hao, Chun‐cheng;
Luo, Jia‐ning;
Xu, Cui‐yang;
Zhao, Xin‐yu;
Zhong, Zhen‐bin;
Hu, Xiao‐nan;
Jin, Xiao‐ming;
Ge, Xiaofeng

Publication type:

Article

Current status and progress of concurrent chemoradiotherapy in patients with locally advanced non‐small cell lung cancer prior to the approval of durvalumab.

Published in:

Thoracic Cancer, 2020, v. 11, n. 4, p. 1005, doi. 10.1111/1759-7714.13357

By:

Fukui, Tomoya;
Hosotani, Shinji;
Soda, Itaru;
Ozawa, Takahiro;
Kusuhara, Seiichiro;
Kakegawa, Mikiko I.;
Kasajima, Masashi;
Hiyoshi, Yasuhiro;
Igawa, Satoshi;
Yokoba, Masanori;
Mitsufuji, Hisashi;
Kubota, Masaru;
Katagiri, Masato;
Sasaki, Jiichiro;
Ishiyama, Hiromichi;
Naoki, Katsuhiko

Publication type:

Article

Application of electrochemical biosensors in tumor cell detection.

Published in:

Thoracic Cancer, 2020, v. 11, n. 4, p. 840, doi. 10.1111/1759-7714.13353

By:

Zhang, Zhenhua;
Li, Qingchao;
Du, Xin;
Liu, Min

Publication type:

Article

Utility of CT radiomics for prediction of PD‐L1 expression in advanced lung adenocarcinomas.

Published in:

Thoracic Cancer, 2020, v. 11, n. 4, p. 993, doi. 10.1111/1759-7714.13352

By:

Yoon, Jiyoung;
Suh, Young Joo;
Han, Kyunghwa;
Cho, Hyoun;
Lee, Hye‐Jeong;
Hur, Jin;
Choi, Byoung Wook

Publication type:

Article

Class A CpG oligodeoxynucleotide inhibits IFN‐γ‐induced signaling and apoptosis in lung cancer.

Published in:

Thoracic Cancer, 2020, v. 11, n. 4, p. 983, doi. 10.1111/1759-7714.13351

By:

Teranishi, Shuhei;
Kobayashi, Nobuaki;
Katakura, Seigo;
Kamimaki, Chisato;
Kubo, Sousuke;
Shibata, Yuji;
Yamamoto, Masaki;
Kudo, Makoto;
Piao, Hongmei;
Kaneko, Takeshi

Publication type:

Article

Overexpression of JAB1 promotes malignant behavior and predicts poor prognosis in esophageal squamous cell carcinoma.

Published in:

Thoracic Cancer, 2020, v. 11, n. 4, p. 973, doi. 10.1111/1759-7714.13350

By:

Shen, Qi;
Shang, Bin;
Jiang, Bin;
Wang, Yu;
Wang, Zhou;
Chen, Gang

Publication type:

Article

Cone‐beam CT radiomics features might improve the prediction of lung toxicity after SBRT in stage I NSCLC patients.

Published in:

Thoracic Cancer, 2020, v. 11, n. 4, p. 964, doi. 10.1111/1759-7714.13349

By:

Qin, Qingjin;
Shi, Anhui;
Zhang, Ran;
Wen, Qiang;
Niu, Tianye;
Chen, Jinhu;
Qiu, Qingtao;
Wan, Yidong;
Sun, Xiaorong;
Xing, Ligang

Publication type:

Article

MiRNA‐96‐5p impacts the progression of breast cancer through targeting FOXO3.

Published in:

Thoracic Cancer, 2020, v. 11, n. 4, p. 956, doi. 10.1111/1759-7714.13348

By:

Yin, Ziyi;
Wang, Wenyan;
Qu, Gengbao;
Wang, Lin;
Wang, Xiang;
Pan, Qin

Publication type:

Article

Clinical diagnosis and treatment of immune checkpoint inhibitors‐related endocrine dysfunction.

Published in:

Thoracic Cancer, 2020, v. 11, n. 4, p. 1099, doi. 10.1111/1759-7714.13347

By:

Duan, Lian;
Wang, Linjie;
Wang, Hanping;
Si, Xiaoyan;
Zhang, Li;
Liu, Xiaowei;
Li, Yue;
Guo, Xiaoxiao;
Zhou, Jiaxin;
Zhu, Huijuan

Publication type:

Article

Predictive value of CD73 expression for the efficacy of immune checkpoint inhibitors in NSCLC.

Published in:

Thoracic Cancer, 2020, v. 11, n. 4, p. 950, doi. 10.1111/1759-7714.13346

By:

Ishii, Hidenobu;
Azuma, Koichi;
Kawahara, Akihiko;
Kinoshita, Takashi;
Matsuo, Norikazu;
Naito, Yoshiko;
Tokito, Takaaki;
Yamada, Kazuhiko;
Akiba, Jun;
Hoshino, Tomoaki

Publication type:

Article

The safety and feasibility of intraoperative near‐infrared fluorescence imaging with indocyanine green in thoracoscopic sympathectomy for primary palmar hyperhidrosis.

Published in:

Thoracic Cancer, 2020, v. 11, n. 4, p. 943, doi. 10.1111/1759-7714.13345

By:

Pei, Guotian;
Liu, Yanguo;
Liu, Qiang;
Min, Xianjun;
Yang, Yingshun;
Wang, Shuai;
Liu, Jun;
Wang, Jun;
Huang, Yuqing

Publication type:

Article

Efficacy of transcutaneous electrical acupoint stimulation combined with general anesthesia for sedation and postoperative analgesia in minimally invasive lung cancer surgery: A randomized, double‐blind, placebo‐controlled trial.

Published in:

Thoracic Cancer, 2020, v. 11, n. 4, p. 928, doi. 10.1111/1759-7714.13343

By:

Chen, Jiheng;
Zhang, Yunxiao;
Li, Xiaoxi;
Wan, You;
Ji, Xinqiang;
Wang, Wei;
Kang, Xiaozheng;
Yan, Wanpu;
Fan, Zhiyi

Publication type:

Article

The role of IL‐6 in immunotherapy of non‐small cell lung cancer (NSCLC) with immune‐related adverse events (irAEs).

Published in:

Thoracic Cancer, 2020, v. 11, n. 4, p. 835, doi. 10.1111/1759-7714.13341

By:

Ke, Wanhai;
Zhang, Li;
Dai, Yan

Publication type:

Article

The preoperative platelet distribution width: A predictive factor of the prognosis in patients with non‐small cell lung cancer.

Published in:

Thoracic Cancer, 2020, v. 11, n. 4, p. 918, doi. 10.1111/1759-7714.13340

By:

Liu, Chang;
Zhang, Hua;
Qi, Qi;
Zhang, Bin;
Yue, Dongsheng;
Wang, Changli

Publication type:

Article

Clinical diagnosis and treatment of immune checkpoint inhibitor‐associated adverse events in the digestive system.

Published in:

Thoracic Cancer, 2020, v. 11, n. 4, p. 829, doi. 10.1111/1759-7714.13338

By:

Li, Yue;
Kang, Xiaohui;
Wang, Hanping;
Guo, Xiaoxiao;
Zhou, Jiaxin;
Duan, Lian;
Si, Xiaoyan;
Zhang, Li;
Liu, Xiaowei;
Qian, Jiaming

Publication type:

Article

Surgeons' preference sublobar resection for stage I NSCLC less than 3 cm.

Published in:

Thoracic Cancer, 2020, v. 11, n. 4, p. 907, doi. 10.1111/1759-7714.13336

By:

Huang, Chien‐Sheng;
Hsu, Po‐Kuei;
Chen, Chun‐Ku;
Yeh, Yi‐Chen;
Hsu, Han‐Shui;
Shih, Chun‐Che;
Huang, Biing‐Shiun

Publication type:

Article

Different administration routes of recombinant human endostatin combined with concurrent chemoradiotherapy might lead to different efficacy and safety profile in unresectable stage III non‐small cell lung cancer: Updated follow‐up results from two phase II trials

Published in:

Thoracic Cancer, 2020, v. 11, n. 4, p. 898, doi. 10.1111/1759-7714.13333

By:

Honglian, Ma;
Zhouguang, Hui;
Fang, PENG;
Lujun, Zhao;
Dongming, Li;
Yujin, Xu;
Yong, Bao;
Liming, Xu;
Yirui, Zhai;
Xiao, Hu;
Jin, Wang;
Yue, Kong;
Lvhua, Wang;
Ming, Chen

Publication type:

Article

Long‐term response with durvalumab after chemoradiotherapy for pulmonary pleomorphic carcinoma: A case report.

Published in:

Thoracic Cancer, 2020, v. 11, n. 4, p. 1090, doi. 10.1111/1759-7714.13331

By:

Yorozuya, Takafumi;
Taya, Tetsuya;
Yasuda, Kento;
Nagano, Yutaro;
Shioya, Makoto;
Chiba, Hirofumi;
Takahashi, Hiroki

Publication type:

Article

Prognostic value of baseline hemoglobin‐to‐red blood cell distribution width ratio in small cell lung cancer: A retrospective analysis.

Published in:

Thoracic Cancer, 2020, v. 11, n. 4, p. 888, doi. 10.1111/1759-7714.13330

By:

Wu, Fangfang;
Yang, Shaoxing;
Tang, Xiuhua;
Liu, Wenjing;
Chen, Haoran;
Gao, Hongjun

Publication type:

Article

Circ‐IGF1R inhibits cell invasion and migration in non‐small cell lung cancer.

Published in:

Thoracic Cancer, 2020, v. 11, n. 4, p. 875, doi. 10.1111/1759-7714.13329

By:

Xu, Zhanyu;
Xiang, Weiwei;
Chen, Wenjie;
Sun, Yu;
Qin, Fanglu;
Wei, Jiangbo;
Yuan, Liqiang;
Zheng, Liping;
Li, Shikang

Publication type:

Article

Trend analysis of lung cancer mortality and years of life lost (YLL) rate from 1999 to 2016 in Tianjin, China: Does the lung cancer burden in rural areas exceed that of urban areas?

Published in:

Thoracic Cancer, 2020, v. 11, n. 4, p. 867, doi. 10.1111/1759-7714.13314

By:

Zheng, Wenlong;
Zhang, Hui;
Shen, Chengfeng;
Zhang, Shuang;
Wang, Dezheng;
Li, Wei;
Jiang, Guohong

Publication type:

Article

Identification and validation of key genes with prognostic value in non‐small‐cell lung cancer via integrated bioinformatics analysis.

Published in:

Thoracic Cancer, 2020, v. 11, n. 4, p. 851, doi. 10.1111/1759-7714.13298

By:

Wang, Li;
Qu, Jialin;
Liang, Yu;
Zhao, Deze;
Rehman, Faisal UL;
Qin, Kang;
Zhang, Xiaochun

Publication type:

Article

Issue Information.

Published in:: Thoracic Cancer, 2020, v. 11, n. 4, p. 827, doi. 10.1111/1759-7714.13111
Publication type:: Article